IL0011651580 - Common Stock
PAINREFORM LTD
NASDAQ:PRFX (5/15/2024, 7:03:31 PM)
After market: 0.84 +0.04 (+4.99%)0.8001
-0.05 (-6.31%)
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
PAINREFORM LTD
65 Yigal Alon St.
TEL AVIV-YAFO 6745442
P: 97237177051
CEO: Ilan Hadar
Employees: 6
Website: https://painreform.com/
InvestorPlace - Stock Market News, Stock Advice & Trading Tips PainReform (NASDAQ:PRFX) just reported results for the first quarter of 2024.Pa...
PRFX stock results show that PainReform missed analyst estimates for earnings per share the first quarter of 2024.
Reaches 50% enrollment in the second part of its Phase 3 clinical trial of PRF-110 in bunionectomy Remains on track to announce top-line data in Q3 2024...
TEL AVIV, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (
TEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty...
Pre-market stock movers are worth diving into on Wednesday morning to get ready for all of the hottest news moving shares today!
Here you can normally see the latest stock twits on PRFX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: